Dechra Pharmaceuticals Share Discussion Threads

[montyhedge] 22/6/2021 12:29

Looked into this more, looks like forward p.e 39, quite cheap for a growth company.
More importantly with its market cap, this should be a candidate into the FTSE 100, tracker funds will have to buy. This is going a lot higher, slowly buy surely.

[davr0s] 08/6/2021 16:08

Yeah shush!

[robertball] 08/6/2021 09:21

And few posts or comments

[johnrxx99] 17/4/2021 05:40

And now GDP38.50. Consensus rating increase to stronger - outperform

[johnrxx99] 15/1/2021 02:48

And an all time high above GBP36.

[whatja] 14/1/2021 21:17

Decent trading update today. Plenty of detail, market generally positive

[davidosh] 14/12/2020 01:53

Just to mention that the Xmas MelloMonday special guest may mention Dechra and I think shareholders and potential investors will appreciate his thoughts. There is an interview tonight with Keith Ashworth Lord who is a highly respected fund manager and well worth listening to. Keith's fund Castlefield are of course one of the larger shareholders in Dechra and I think it is one of their top ten positions.

The Mello Monday event starts at 6pm
The full programme is available on the website.

Also of interest may be the MelloBASH... The analysts, fund manager and well known investors on the panel will give their honest verdicts on whether four companies are a Buy Avoid Sell or Hold at this current juncture in the markets.



All investors welcome and if you use the code MMTADVFN50 you will get a half price ticket. Great investor content and entertainment. We had nearly 400 investors attend last month so these are very popular.

[montyhedge] 25/11/2020 07:59

Always a bell ringing moment when a director sells. I like to follow them.

[steeplejack] 27/10/2020 09:57

Good start to the year.In my experience,people love their pets MORE than their family!

[johnrxx99] 16/9/2020 07:31

IMO a firm hold and forget. People love their pets as much as their family.

[steeplejack] 07/9/2020 06:56

The interim dividend was up 8.3% so the final dividend has been increased by a similar amount.The earnings figures are modestly ie about 2% better than consensus,broadly in line.

[lasata] 07/9/2020 06:50

Was the increased dividend expected?

[steeplejack] 07/9/2020 06:40

I think a company that increases profits in the current environment is fairly 'special'.The shares are highly rated but justifiably.

[lasata] 07/9/2020 06:34

Ok results...nothing special. Good to see dividend is up

[steeplejack] 09/7/2020 13:11

"Trading in the year was robust and in line with management expectations."Preliminary results,Monday 7 Sept 2020.

[1hjones] 08/7/2020 07:44

Has anyone else picked up on this news from MWI in the US?

Working with a UK plc premier?? Interesting....this stock is only 40p with a high of £2+

hxxps://www.mwiah.com/newsroom/press-releases/mwi-animal-health-announces-new-offerings-to-alleviate-financial-burdens-of-pet-care

[1hjones] 08/7/2020 07:44

Has anyone else picked up on this news from MWI in the US?

Working with a UK plc premier?? Interesting....this stock is only 40p with a high of £2+

hxxps://www.mwiah.com/newsroom/press-releases/mwi-animal-health-announces-new-offerings-to-alleviate-financial-burdens-of-pet-care

[steeplejack] 29/6/2020 08:33

Indeed,grandma and pa get stuck in a second rate care home while the pooch gets a cuddle on the sofa.Its a furry thing I guess plus animals are generally more loyal than human beings who are emotionally shifty :)

[lindowcross] 29/6/2020 07:43

Yes. One of my largest holdings. Owners don't skimp when it comes to their pets. Quite right too.

[johnrxx99] 04/6/2020 06:25

Oh so quiet on here - love it.

[johnrxx99] 20/5/2020 09:19

Come back is impressive - nearly an Omaha quality.

[montyhedge] 21/10/2019 09:28

Problem is crazy high p.e, any hiccup shareprice gets hit hard.

[sarkasm] 15/9/2019 11:48

Turnover PS 469.35 p
Pre-Tax Profit PS 27.08 p
Retained Profit PS 2.44 p
Cash PS 78.23 p
Net Cash PS -36.82 p
Net Tangible Asset Value PS * -173.30 p
Net Asset Value PS 495.95 p

[sarkasm] 15/9/2019 11:46

Summary

The company has poor fundamentals for a short-term investment strategy.

Strengths

Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Analysts covering this company mostly recommend stock overweighting or purchase.
Within the weekly time frame the stock shows a bullish technical configuration above the support level at 2478 GBp

Weaknesses

Stock prices approach a strong long-term resistance in weekly data at GBp 3036.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Based on current prices, the company has particularly high valuation levels.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 90.41 times its estimated earnings per share for the ongoing year.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the past seven days, analysts have been lowering their EPS expectations for the company.
For the last few months, analysts have been revising downwards their earnings forecast.